| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.75B | 19.50B | 17.28B | 18.50B | 22.75B | 18.04B |
| Gross Profit | 3.66B | 3.89B | 4.10B | 4.44B | 5.44B | 4.91B |
| EBITDA | 961.82M | 1.26B | 1.32B | 1.59B | 2.27B | 2.26B |
| Net Income | -197.79M | -96.66M | 172.59M | 498.44M | 906.71M | 563.75M |
Balance Sheet | ||||||
| Total Assets | 27.74B | 29.20B | 26.66B | 26.43B | 25.69B | 22.35B |
| Cash, Cash Equivalents and Short-Term Investments | 3.42B | 3.36B | 3.29B | 3.26B | 4.01B | 2.90B |
| Total Debt | 8.65B | 10.58B | 7.55B | 6.58B | 5.50B | 4.00B |
| Total Liabilities | 16.45B | 17.58B | 15.07B | 14.73B | 14.96B | 12.55B |
| Stockholders Equity | 11.12B | 11.46B | 11.39B | 11.51B | 10.52B | 9.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.53B | -429.10M | -968.36M | -68.92M | 1.44B |
| Operating Cash Flow | 0.00 | -614.73M | 1.23B | 427.82M | 1.35B | 2.15B |
| Investing Cash Flow | 0.00 | -1.26B | -1.62B | -1.31B | -1.43B | -716.43M |
| Financing Cash Flow | 0.00 | 1.90B | 444.32M | 214.68M | 1.15B | -748.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥364.86B | 19.71 | ― | 1.17% | 29.22% | 29.50% | |
78 Outperform | ¥99.18B | 9.96 | ― | 3.85% | 19.61% | 25.91% | |
74 Outperform | ¥314.37B | 11.92 | 7.86% | 2.55% | 5.68% | 41.20% | |
71 Outperform | ¥146.60B | 13.55 | ― | 2.82% | 15.90% | 313.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥139.14B | 26.06 | 2.64% | 2.30% | 0.90% | 15.74% | |
53 Neutral | ¥6.81B | -57.55 | ― | 2.05% | 12.83% | -156.39% |